Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification
-
Published:2024-08-23
Issue:9
Volume:12
Page:1745
-
ISSN:2076-2607
-
Container-title:Microorganisms
-
language:en
-
Short-container-title:Microorganisms
Author:
Fonseca Paula Luize Camargos1ORCID, Braga-Paz Isabela1, de Araújo e Santos Luiza Campos Guerra1, Dias Rillery Calixto1, de Souza Carolina Senra Alves2, Carvalho Nara Oliveira3ORCID, Queiroz Daniel Costa1ORCID, Alves Hugo José1, de Araújo João Locke Ferreira1ORCID, Moreira Filipe Romero Rebello4, Menezes Mariane Talon4ORCID, Menezes Diego1ORCID, Silva Aryel Beatriz Paz e1, Ferreira Jorge Gomes Goulart1, Adelino Talita Emile Ribeiro5, Bernardes André Felipe Leal5, Carobin Natália Virtude6, Carvalho Renée Silva2, Ferrari Carolina Zaniboni2ORCID, Guimarães Natália Rocha5, Lamounier Ludmila Oliveira5, Souza Fernanda Gil1, Vargas Luisa Aimeé2, Ribeiro Marisa de Oliveira7, Arruda Monica Barcellos7, Alvarez Patricia7, Moreira Rennan Garcias1, de Oliveira Eneida Santos8, Sabino Adriano de Paula6ORCID, de Oliveira Jaqueline Silva2, Januário José Nélio3, Iani Felipe Campos de Melo5, Souza Renan Pedra de1ORCID, Aguiar Renato Santana19ORCID
Affiliation:
1. Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil 2. Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil 3. Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil 4. Departamento de Genetica, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil 5. Fundacao Ezequiel Dias (FUNED), Belo Horizonte 30510-010, Brazil 6. Laboratório Institucional de Pesquisa em Biomarcadores, Laboratório de Hematologia Clínica, Departamento de Análises Clínicas e Toxicológicas; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil 7. Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil 8. Secretaria Municipal de Saúde de Belo Horizonte, Belo Horizonte 30130-012, Brazil 9. Instituto D’OR de Pesquisa e Ensino, Rio de Janeiro 22281-100, Brazil
Abstract
Brazil is one of the countries most affected by COVID-19, with the highest number of deaths recorded. Brazilian Health Institutions have reported four main peaks of positive COVID-19 cases. The last two waves were characterized by the emergence of the VOC Omicron and its sublineages. This study aimed to conduct a retrospective surveillance study illustrating the emergence, dissemination, and diversification of the VOC Omicron in 15 regional health units (RHUs) in MG, the second most populous state in Brazil, by combining epidemiological and genomic data. A total of 5643 confirmed positive COVID-19 samples were genotyped using the panels TaqMan SARS-CoV-2 Mutation and 4Plex SC2/VOC Bio-Manguinhos to define mutations classifying the BA.1, BA.2, BA.4, and BA.5 sublineages. While sublineages BA.1 and BA.2 were more prevalent during the third wave, BA.4 and BA.5 dominated the fourth wave in the state. Epidemiological and viral genome data suggest that age and vaccination with booster doses were the main factors related to clinical outcomes, reducing the number of deaths, irrespective of the Omicron sublineages. Complete genome sequencing of 253 positive samples confirmed the circulation of the BA.1, BA.2, BA.4, and BA.5 subvariants, and phylogenomic analysis demonstrated that the VOC Omicron was introduced through multiple international events, followed by transmission within the state of MG. In addition to the four subvariants, other lineages have been identified at low frequency, including BQ.1.1 and XAG. This integrative study reinforces that the evolution of Omicron sublineages was the most significant factor driving the highest peaks of positive COVID-19 cases without an increase in more severe cases, prevented by vaccination boosters.
Funder
Rede Corona-ômica BR MCTI/FINEP affiliated with RedeVírus/MCTI Laboratórios de Campanha MCTI/FINEP Instituto Todos pela Saúde—ITpS CNPq FINEP CAPES FAPEMIG
Reference42 articles.
1. (2024, April 15). Brasil Coronavírus—Brasil 2024, Available online: https://covid.saude.gov.br/. 2. De Menezes, M.T., Moreira, F.R.R., Whittaker, C., Santos, F.M., Queiroz, D.C., Geddes, V., Fonseca, P.L.C., De Jesus, J.G., Mendes-Oliveira, F., and Reis-Souza, V. (2023). Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil. Viruses, 15. 3. The Biological and Clinical Significance of Emerging SARS-CoV-2 Variants;Tao;Nat. Rev. Genet.,2021 4. The Evolution of SARS-CoV-2;Markov;Nat. Rev. Microbiol.,2023 5. Routes for COVID-19 Importation in Brazil;Candido;J. Travel Med.,2020
|
|